Leidos Holdings, Inc. (LDOS) financials: revenue, earnings and cash flow
Fiscal 2016–2025 + TTM · from SEC filings · data as of November 13, 2026
Summary
Leidos’s revenue went from $7.0B in fiscal 2016 to $17.2B in fiscal 2025, growth of about 10.4% a year.
Net income in fiscal 2025 was $1.4B, a net margin of 8.4%; the highest of the period.
Over the twelve months to October 2, 2026, revenue was $17.8B and net income $1.4B.
Free cash flow was $1.6B in fiscal 2025 and positive in 10 of the 10 years shown.
The diluted share count rose 25% over the period (dilution).
Revenue, profit and cash flow by year
Income statement
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $17.8B | $17.2B | $16.7B | $15.4B | $14.4B | $13.7B | $12.3B | $11.1B | $10.2B | $10.2B | $7.0B |
| Gross profit | $3.1B | $3.1B | $2.8B | $2.2B | $2.1B | $2.0B | $1.7B | $1.5B | $1.5B | $1.4B | $940M |
| Operating income | $2.0B | $2.1B | $1.8B | $621M | $1.1B | $1.2B | $998M | $912M | $749M | $559M | $417M |
| Net income | $1.4B | $1.4B | $1.3B | $199M | $685M | $753M | $628M | $667M | $581M | $366M | $244M |
| EPS (diluted) | $11.17 | $11.14 | $9.22 | $1.44 | $4.96 | $5.27 | $4.36 | $4.60 | $3.80 | $2.38 | $2.35 |
| R&D | — | $187M | $150M | $128M | $116M | $109M | $73M | $49M | $46M | $42M | $44M |
| Revenue growth | — | +3.1% | +7.9% | +7.2% | +4.8% | +11.7% | +10.8% | +8.8% | +0.2% | +44.4% | +38.5% |
Cash flow
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $2.1B | $1.8B | $1.4B | $1.2B | $992M | $1.0B | $1.3B | $992M | $768M | $526M | $449M |
| Capital spending | -$153M | -$125M | -$149M | -$207M | -$129M | -$104M | -$183M | -$121M | -$73M | -$81M | -$29M |
| Free cash flow | $2.0B | $1.6B | $1.3B | $980M | $863M | $929M | $1.2B | $871M | $695M | $445M | $420M |
| Dividends paid | $217M | $211M | $208M | $201M | $199M | $199M | $196M | $198M | $0 | $0 | $993M |
| Buybacks | $1.1B | $400M | $850M | $225M | $0 | $237M | $67M | $25M | $167M | $0 | $0 |
| Stock-based pay | $102M | $95M | $85M | $77M | $73M | $67M | $62M | $52M | $44M | $43M | $35M |
Balance sheet
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | — | $1.1B | $849M | $641M | $516M | $727M | $524M | $668M | $327M | $390M | $376M |
| Debt | — | $5.3B | $5.4B | $5.3B | $5.6B | $5.8B | $5.4B | $3.4B | $3.1B | $3.1B | $3.3B |
| Equity | — | $4.9B | $4.4B | $4.2B | $4.3B | $4.3B | $3.9B | $3.4B | $3.3B | $3.4B | $3.1B |
| Total assets | — | $13.5B | $13.0B | $12.7B | $13.1B | $13.3B | $12.5B | $9.4B | $8.8B | $9.0B | $9.1B |
| Shares (diluted) | 125M | 130M | 136M | 138M | 138M | 143M | 144M | 145M | 153M | 154M | 104M |
Margins and returns
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 17.6% | 18.0% | 16.8% | 14.5% | 14.5% | 14.7% | 14.1% | 14.0% | 14.8% | 14.1% | 13.4% |
| Operating margin | 11.5% | 12.3% | 11.0% | 4.0% | 7.6% | 8.4% | 8.1% | 8.2% | 7.3% | 5.5% | 5.9% |
| Net margin | 8.0% | 8.4% | 7.5% | 1.3% | 4.8% | 5.5% | 5.1% | 6.0% | 5.7% | 3.6% | 3.5% |
| FCF margin | 11.0% | 9.5% | 7.7% | 6.3% | 6.0% | 6.8% | 9.4% | 7.8% | 6.8% | 4.4% | 6.0% |
| ROIC | — | 15.8% | 14.2% | 3.4% | 8.6% | 9.0% | 8.6% | 10.3% | 11.1% | 8.0% | 5.0% |
| ROE | — | 29.4% | 28.4% | 4.7% | 15.9% | 17.5% | 16.3% | 19.5% | 17.6% | 10.9% | 7.8% |
Frequently asked questions
What is Leidos’s annual revenue?
$17.2B in fiscal 2025 and $17.8B over the twelve months to October 2, 2026.
How much profit does Leidos make?
Net income was $1.4B in fiscal 2025 (net margin 8.4%).
Is Leidos’s revenue growing?
Yes: revenue rose 3.1% in fiscal 2025 compared with the year before.
From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.